vs
美国运通（AXP）与FENNEC PHARMACEUTICALS INC.（FENC）财务数据对比。点击上方公司名可切换其他公司
美国运通的季度营收约是FENNEC PHARMACEUTICALS INC.的1.4倍（$18.9M vs $13.8M），美国运通净利率更高（15.7% vs -34.7%，领先50.5%），FENNEC PHARMACEUTICALS INC.同比增速更快（73.8% vs 11.4%），过去两年FENNEC PHARMACEUTICALS INC.的营收复合增速更高（-26.3% vs -95.6%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
Fennec制药是一家生物制药企业，专注于开发和商业化可降低儿童癌症患者治疗相关副作用的特种疗法，核心产品针对化疗引发的耳毒性，主要市场覆盖北美，服务肿瘤诊疗机构及儿童肿瘤患者群体。
AXP vs FENC — 直观对比
营收规模更大
AXP
是对方的1.4倍
$13.8M
营收增速更快
FENC
高出62.4%
11.4%
净利率更高
AXP
高出50.5%
-34.7%
两年增速更快
FENC
近两年复合增速
-95.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $13.8M |
| 净利润 | $3.0M | $-4.8M |
| 毛利率 | — | — |
| 营业利润率 | — | -18.5% |
| 净利率 | 15.7% | -34.7% |
| 营收同比 | 11.4% | 73.8% |
| 净利润同比 | 15.0% | -141.1% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPFENC
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | $13.8M | ||
| Q3 25 | $10.4B | $12.5M | ||
| Q2 25 | $10.3B | $9.7M | ||
| Q1 25 | $9.6B | $8.8M | ||
| Q4 24 | $10.0B | $7.9M | ||
| Q3 24 | $9.7B | $7.0M | ||
| Q2 24 | $9.8B | $7.3M |
净利润AXPFENC
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | $-4.8M | ||
| Q3 25 | $2.9B | $-638.0K | ||
| Q2 25 | $2.9B | $-3.2M | ||
| Q1 25 | $2.6B | $-1.2M | ||
| Q4 24 | $2.2B | $-2.0M | ||
| Q3 24 | $2.5B | $-5.7M | ||
| Q2 24 | $3.0B | $-5.6M |
营业利润率AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | -18.5% | ||
| Q3 25 | 36.7% | -1.5% | ||
| Q2 25 | 34.4% | -28.3% | ||
| Q1 25 | 34.6% | -9.2% | ||
| Q4 24 | 27.7% | -11.8% | ||
| Q3 24 | 33.0% | -74.6% | ||
| Q2 24 | 38.6% | -69.4% |
净利率AXPFENC
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | -34.7% | ||
| Q3 25 | 27.9% | -5.1% | ||
| Q2 25 | 28.0% | -32.7% | ||
| Q1 25 | 26.8% | -13.3% | ||
| Q4 24 | 21.8% | -25.0% | ||
| Q3 24 | 25.8% | -82.2% | ||
| Q2 24 | 30.7% | -76.5% |
每股收益（稀释后）AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | $-0.17 | ||
| Q3 25 | $4.14 | $-0.02 | ||
| Q2 25 | $4.08 | $-0.11 | ||
| Q1 25 | $3.64 | $-0.04 | ||
| Q4 24 | $3.04 | $-0.02 | ||
| Q3 24 | $3.49 | $-0.21 | ||
| Q2 24 | $4.15 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $36.8M |
| 总债务越低越好 | $60.4M | — |
| 股东权益账面价值 | $34.0M | $35.5M |
| 总资产 | $308.9M | $70.6M |
| 负债/权益比越低杠杆越低 | 1.78× | — |
8季度趋势，按日历期对齐
现金及短期投资AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | $36.8M | ||
| Q3 25 | $1.3B | $21.9M | ||
| Q2 25 | $197.0M | $18.7M | ||
| Q1 25 | $261.0M | $22.7M | ||
| Q4 24 | $221.0M | $26.6M | ||
| Q3 24 | $120.0M | $40.3M | ||
| Q2 24 | $188.0M | $43.1M |
总债务AXPFENC
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | — | ||
| Q3 25 | $57.8B | $19.4M | ||
| Q2 25 | $58.2B | $19.4M | ||
| Q1 25 | $51.2B | $19.4M | ||
| Q4 24 | $49.7B | $19.3M | ||
| Q3 24 | $53.5B | $32.1M | ||
| Q2 24 | $51.5B | $31.8M |
股东权益AXPFENC
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | $35.5M | ||
| Q3 25 | $32.4B | $-4.5M | ||
| Q2 25 | $32.3B | $-7.5M | ||
| Q1 25 | $31.2B | $-5.9M | ||
| Q4 24 | $30.3B | $-5.9M | ||
| Q3 24 | $29.7B | $-5.2M | ||
| Q2 24 | $29.5B | $-1.4M |
总资产AXPFENC
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | $70.6M | ||
| Q3 25 | $297.6B | $49.3M | ||
| Q2 25 | $295.6B | $44.9M | ||
| Q1 25 | $282.2B | $46.4M | ||
| Q4 24 | $271.5B | $44.9M | ||
| Q3 24 | $271.0B | $58.9M | ||
| Q2 24 | $272.2B | $63.2M |
负债/权益比AXPFENC
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.78× | — | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | — | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $-6.0M | ||
| Q3 25 | $6.2B | $1.5M | ||
| Q2 25 | $4.4B | $-3.7M | ||
| Q1 25 | $4.8B | $-4.3M | ||
| Q4 24 | $5.8B | $-1.5M | ||
| Q3 24 | $-1.8B | $-2.2M | ||
| Q2 24 | $4.5B | $-8.4M |
自由现金流AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $-2.3B | — | ||
| Q2 24 | $4.0B | — |
自由现金流率AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | — | ||
| Q3 25 | 53.6% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 45.0% | — | ||
| Q4 24 | 53.1% | — | ||
| Q3 24 | -23.3% | — | ||
| Q2 24 | 40.4% | — |
资本支出强度AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 5.8% | — |
现金转化率AXPFENC
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | — | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
FENC
暂无分部数据
